Literature DB >> 6984356

Natural resistance mechanisms may play a role in protection against chemical carcinogenesis.

P Brodt, J Gordon.   

Abstract

Mice deprived of B lymphocytes by the chronic administration of anti-IgM antibodies have been shown to possess a heightened natural resistance (NR) to micro-organisms, to parental bone marrow, and to natural killer (NK)-sensitive tumors in vitro and in vivo. Experiments described in this communication indicate that the latent period of primary tumors induced by the injection of methylcholanthrene (MC) is also prolonged in these mice. This observation suggests that NR mechanisms may provide protection against primary chemically induced tumors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984356     DOI: 10.1007/BF00205312

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  22 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Immunologic responsiveness and the induction of experimental neoplasms.

Authors:  L W Law
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

3.  Immunologic properties of methylcholanthrene-induced sarcomas of neonatally thymectomized mice.

Authors:  K Nomoto; K Takeya
Journal:  J Natl Cancer Inst       Date:  1969-03       Impact factor: 13.506

4.  Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor.

Authors:  P Brodt; J Gordon
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  Characterization of small lymphocytes in the bone marrow of mice after prolonged treatment with anti-IgM antibodies.

Authors:  D G Osmond; J Gordon
Journal:  Cell Immunol       Date:  1979-01       Impact factor: 4.868

6.  Antitumor immunity in B-lymphocyte-deprived mice. II. In vitro studies.

Authors:  P Brodt; J Gordon
Journal:  Cell Immunol       Date:  1981-11-15       Impact factor: 4.868

7.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

8.  Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12-dimethylbenz(a)anthracene or urethan.

Authors:  N Trainin; M Linker-Israeli; M Small; L Boiato-Chen
Journal:  Int J Cancer       Date:  1967-07-15       Impact factor: 7.396

9.  Nonimmunogenic sarcomas induced by 3-methylcholanthrene treatment of murine fibroblasts in diffusion chambers.

Authors:  G Carbone; G Parmiani
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

10.  The B lymphocyte-deprived mouse as a tool in immunobiology.

Authors:  J Gordon
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

View more
  9 in total

Review 1.  Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.

Authors:  Arya Biragyn; Dan L Longo
Journal:  Semin Cancer Biol       Date:  2012-01-12       Impact factor: 15.707

2.  Generation and identification of tumor-evoked regulatory B cells.

Authors:  Arya Biragyn; Catalina Lee-Chang; Monica Bodogai
Journal:  Methods Mol Biol       Date:  2014

3.  Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

Authors:  Monica Bodogai; Catalina Lee Chang; Katarzyna Wejksza; Jinping Lai; Maria Merino; Robert P Wersto; Ronald E Gress; Andrew C Chan; Charles Hesdorffer; Arya Biragyn
Journal:  Cancer Res       Date:  2013-01-30       Impact factor: 12.701

Review 4.  Cancer systems immunology.

Authors:  Nathan E Reticker-Flynn; Edgar G Engleman
Journal:  Elife       Date:  2020-07-13       Impact factor: 8.140

5.  Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein.

Authors:  C T Siegel; K Schreiber; S C Meredith; G B Beck-Engeser; D W Lancki; C A Lazarski; Y X Fu; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

6.  Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response.

Authors:  Genevieve M Weir; Olga Hrytsenko; Marianne M Stanford; Neil L Berinstein; Mohan Karkada; Robert S Liwski; Marc Mansour
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

Review 7.  B cell-regulated immune responses in tumor models and cancer patients.

Authors:  Carlo Fremd; Florian Schuetz; Christof Sohn; Philipp Beckhove; Christoph Domschke
Journal:  Oncoimmunology       Date:  2013-07-01       Impact factor: 8.110

Review 8.  B cell regulation in cancer and anti-tumor immunity.

Authors:  Anushruti Sarvaria; J Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2017-06-19       Impact factor: 11.530

9.  A new paradigm for an old story: the role of regulatory B cells in cancer.

Authors:  Arya Biragyn; Catalina Lee-Chang
Journal:  Front Immunol       Date:  2012-07-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.